Pluristem Therapeutics to Present at Leading U.S. Industry Conferences
HAIFA, Israel, Sept. 6, 2011 (GLOBE NEWSWIRE) -- Pluristem Therapeutics, Inc. (Nasdaq:PSTI - News) (TASE:PLTR) announced today that Company executives will be presenting at five leading scientific and financial events in the U.S. during the month of September. The presentations will focus on Pluristem's work towards the potential development of placenta-derived stem cell treatments for a variety of illnesses as well as on the company's strategy.
During the month of September, Pluristem will be presenting at the following conferences:
-
35th Annual Meeting of the AATB - September 8-12, Scottsdale, Arizona.
Dr. William R. Prather, Sr. VP Corporate Development, will present: "The use of Placenta-derived MSCs in the treatment of radiation exposure" on Sunday, September 11, 2011 from 3:15 to 4:15 PM
-
Rodman & Renshaw Conference - September 11-13, New York, New York.
Yaky Yanay, VP Finance and CFO, will present: "Cell Therapy and Its Future Role in Reducing Healthcare Spending" on Tuesday, September 13, 2:00-2:25 PM, Sutton Suite
-
UBS Global Life Sciences Conference - September 19-21, New York, New York.
Zami Aberman, Chairman and CEO, will present the Company on Tuesday, September 20, 2011 at 4:00 PM
-
The Cell Therapy Commercialization Summit - September 19-21, 2011, Boston, Massachusetts.
Dr. William R. Prather, Sr. VP of Corporate Development, will present the Company on Monday, September 19, 2011, 9:00-9:30 AM
-
8th Annual Israel Strategic Partner and Venture Conference-Life Sciences and Medical Devices - September 22, 2011, Princeton, New Jersey.
Dr. William R. Prather, Sr. VP of Corporate Development, will present the Company
-
European Society of Cardiology: International Conference on Heart Failure with Preserved Ejection Fraction: Basic mechanisms - September 23-25, Budapest, Hungary.
Frida Grynspan, PhD, VP of Research and Development, will present: "HFPEF and stem cells" Session VII -- Therapy, on Sunday, September 25, 2011 10:20-10:40 AM.